Amarin Corp Plc (AMRN)

[ralphey]

Kiwi you have to change your mindset and understanding . Vascepa may be better at reducing CAD risk but as I have said science alone is not enough to launch a successful pharmaceutical .

Vascepa doesn't reduce CRF and doesn't work directly on DIabetes > Here's the take-home - BP will paint the narrative that DM2, CRF and CAD are all interrelated and the only meds that attacks all 3 are SGLT's. Therefore if you want to attack this common pathway for induction of CAD the oNLY meds that do that are SGLT's

WIth that marketing capability they destroy any market Vascepa has